Screening of myelin-oligodendrocyte-glycoprotein (MOG) antibodies in a large prospective pediatric cohort  with demyelinating syndromes or other encephalitis showed surprisingly high rate of positive results. The study showed implications on diagnostic and therapeutic strategies

In November 2019, CoCoCare consortium came together for the transnational meeting to discuss the progress of the first pilot of the course and start preparing for the second pilot. Colleagues from the European Academy of Neurology also joined the consortium to share their perspective. It was a busy but also a very productive day!

This year SIP celebrated ten years since establishment and on November 7th symposium “Bringing Pain Policy to the Next Decade” was organised in Brussels. More than 200 delegates from 24  countries participate on-site and many more followed symposium online.

“Health data standardisation workshop: looking at the implementation of the 11th International Classification of Diseases (ICD-11) and the International Classification of Functioning, Disability and Health (ICF)” The Societal Impact of Pain (SIP) has organized a workshop "Health data standardisation workshop: looking at the implementation of ICD-11 and ICF" on November 6th 2019. More than 60 scientific experts, decisions makers and patients' representatives gathered at the Permanent Representation of the Federal Republic of Germany to the European Union in Brussels.

Breaking news in Neuro-Oncology

This year the eight edition of the conference entitled "Recent Advances in Clinical and Experimental Research on Dementia and Neurodegenerative Disorders" was held as usually in Bressanone, Italy. The event, which took place from 22 to 24 January, represents an interesting unique in the Italian panorama, starting from the choice to use English as the official language up to the calibre of the speakers.

The former co-chairs of the Scientific Panel on Neuro-oncology, Stefan Oberndorfer and Riccardo Soffietti, explain the work and aims of the panel.

PRIME project kicks off – New mental health project aims to uncover insulin-related mechanisms linking disorders of body and brain

External Interview Prof. Muresanu interviews Prof. G. Waldemar, President- Elect of the BioMed Alliance

Research and innovation is again high on the European Commission’s agenda in 2020.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers ‘which session one should not miss at the upcoming congress in Paris 2020. Please find their answers below!

Alzheimer Europe holds lunch debate examining diagnosis of dementia.

The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe.

The BioMed Alliance and FEAM joined forces to co-organise a workshop exploring opportunities and challenges for maximising the impact of health research in the coming years.